{"title":"第四脑室的玫瑰花状胶质神经元瘤。","authors":"N G Rainov, T Wagner, V Heidecke","doi":"10.1055/s-0029-1242760","DOIUrl":null,"url":null,"abstract":"Introduction & Komori et al. (2002) were the fi rst authors to recognize the existence of a new brain tumor entity, rosette-forming glioneuronal tumor (RGNT) of the fourth ventricle. The authors described 11 cases of this distinctive tumor of the posterior fossa [6] . A few further RGNT cases were published in the following 5 years [1, 2, 4, 5, 8, 10] , eventually leading to the inclusion of RGNT in the 4 th edition of the WHO brain tumor classifi cation as a benign primary brain tumor classifi ed as WHO grade 1 [7, 9] . We describe here the clinical and neuroradiological features of a further patient with RGNT of the fourth ventricle. Our report may contribute to establishing the natural history of these tumors and identifying the best course of treatment.","PeriodicalId":51241,"journal":{"name":"Central European Neurosurgery","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2010-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1055/s-0029-1242760","citationCount":"14","resultStr":"{\"title\":\"Rosette-forming glioneuronal tumor of the fourth ventricle.\",\"authors\":\"N G Rainov, T Wagner, V Heidecke\",\"doi\":\"10.1055/s-0029-1242760\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction & Komori et al. (2002) were the fi rst authors to recognize the existence of a new brain tumor entity, rosette-forming glioneuronal tumor (RGNT) of the fourth ventricle. The authors described 11 cases of this distinctive tumor of the posterior fossa [6] . A few further RGNT cases were published in the following 5 years [1, 2, 4, 5, 8, 10] , eventually leading to the inclusion of RGNT in the 4 th edition of the WHO brain tumor classifi cation as a benign primary brain tumor classifi ed as WHO grade 1 [7, 9] . We describe here the clinical and neuroradiological features of a further patient with RGNT of the fourth ventricle. Our report may contribute to establishing the natural history of these tumors and identifying the best course of treatment.\",\"PeriodicalId\":51241,\"journal\":{\"name\":\"Central European Neurosurgery\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1055/s-0029-1242760\",\"citationCount\":\"14\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Central European Neurosurgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/s-0029-1242760\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2010/3/31 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Central European Neurosurgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0029-1242760","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2010/3/31 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Rosette-forming glioneuronal tumor of the fourth ventricle.
Introduction & Komori et al. (2002) were the fi rst authors to recognize the existence of a new brain tumor entity, rosette-forming glioneuronal tumor (RGNT) of the fourth ventricle. The authors described 11 cases of this distinctive tumor of the posterior fossa [6] . A few further RGNT cases were published in the following 5 years [1, 2, 4, 5, 8, 10] , eventually leading to the inclusion of RGNT in the 4 th edition of the WHO brain tumor classifi cation as a benign primary brain tumor classifi ed as WHO grade 1 [7, 9] . We describe here the clinical and neuroradiological features of a further patient with RGNT of the fourth ventricle. Our report may contribute to establishing the natural history of these tumors and identifying the best course of treatment.